Quantitative analysis of [carbonyl-11C]WAY-100635 PET studies

被引:41
作者
Gunn, RN
Lammertsma, AA
Grasby, PM
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, MRC, Cyclotron Unit, London W12 0NN, England
[2] Free Univ Amsterdam Hosp, PET Ctr, Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
carbonyl-C-11]WAY-100635; 5-HT1A receptor; PET; modeling;
D O I
10.1016/S0969-8051(00)00115-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[carbonyl-C-11]WAY-100635 {[C-11]N-(2-(4-(2-methoxyphenyl)-1-piperazin-1-yl)ethyl)-N- (2-pyridyl)cyclohexanecarboxamide) is a positron-emission tomography (PET) radioligand for in vivo imaging of the 5-hydroxvtryptamine(1A) (5-HT1A) receptor. This paper assesses and summarises various different modeling strategies for the quantitative analysis of the radioligand. The models considered are based on a compartmental description of the ligands behaviour and include both plasma input analyses, requiring the additional monitoring of blood activity, and a reference tissue approach, which relies solely on the tomographic tissue data. Parameter estimates of specific binding are presented for a set of test-retest data, obtained from six normal volunteers who were scanned on two separate occasions, allowing for an assessment of normal binding values and their reproducibility, NUCL MED BIOL 27;5:477-482, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:477 / 482
页数:6
相关论文
共 35 条
[1]  
Abi-Dargham A, 1999, SYNAPSE, V32, P93, DOI 10.1002/(SICI)1098-2396(199905)32:2<93::AID-SYN3>3.0.CO
[2]  
2-C
[3]  
CARSON R, 1997, J CEREB BLOOD FLOW S, V17, pS327
[4]  
Cunningham Vincent J., 1995, Medicinal Chemistry Research, V5, P79
[5]   PET imaging of serotonin 1A receptor binding in depression [J].
Drevets, WC ;
Frank, E ;
Price, JC ;
Kupfer, DJ ;
Holt, D ;
Greer, PJ ;
Huang, YY ;
Gautier, C ;
Mathis, C .
BIOLOGICAL PSYCHIATRY, 1999, 46 (10) :1375-1387
[6]   PET-characterization of [carbonyl-C-11]WAY-100635 binding to 5-HT1A receptors in the primate brain [J].
Farde, L ;
Ginovart, N ;
Ito, H ;
Lundkvist, C ;
Pike, VW ;
McCarron, JA ;
Halldin, C .
PSYCHOPHARMACOLOGY, 1997, 133 (02) :196-202
[7]  
Farde L, 1998, J NUCL MED, V39, P1965
[8]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[9]   Multisubject fMRI studies and conjunction analyses [J].
Friston, KJ ;
Holmes, AP ;
Price, CJ ;
Büchel, C ;
Worsley, KJ .
NEUROIMAGE, 1999, 10 (04) :385-396
[10]   Parametric imaging of ligand-receptor binding in PET using a simplified reference region model [J].
Gunn, RN ;
Lammertsma, AA ;
Hume, SP ;
Cunningham, VJ .
NEUROIMAGE, 1997, 6 (04) :279-287